Search

everythinglearnresearchcommunity

for

Search:↓

A new medical syndrome may include skin changes, hair loss, sweating issues, bone malformations, leg swelling, and low cortisol.

Hair follicle stem cells are similar to mesenchymal stem cells and can become neural-like cells under certain conditions.

BMPs are crucial for hair growth and their decrease by androgens leads to hair loss.

Dermal stem cells help regenerate hair follicles and heal skin wounds.

Alstonia boonei phytochemicals show promise as alternative treatments for BPH with fewer side effects than current drugs.

Smaller substituents at C-17 enhance the inhibitory activity of progesterone derivatives on 5alpha-reductase.

5-alpha-reductase inhibitors help treat urinary symptoms from an enlarged prostate.

Fesoterodine is effective and safe for elderly patients with overactive bladder.

Scientists made a chemical (compound 4e) that can be applied on skin to reduce oil production, which can help with acne, but it might cause skin sensitivity to light.

Metabolite 7 is a strong inhibitor for Alzheimer's disease management.

Blocking CYP17A1 enzyme may help improve certain brain function issues related to dopamine.

The Androgen Receptor could be a target for treating diseases like cancer, but more research is needed to confirm the effectiveness of potential treatments.

Adenosine receptors could be promising targets for treating inflammatory skin diseases like psoriasis.

New compounds show promise for treating hair loss, enlarged prostate, and prostate cancer, with some being more effective and having different side effects than current treatments.

ATP helps prevent skin damage from vandetanib by reducing stress.

Finasteride may improve prostate cancer treatment outcomes.

Compounds 4, 4b, and 4c effectively inhibit an enzyme linked to testosterone conversion without significant toxicity.

Eclipta alba extract reduces ulcers and protects the stomach in rats.

Long-term antiandrogen use may increase aggressive prostate cancer risk.

Cepharanthine analogues, especially tetrandrine, show potential for treating COVID-19.

Different drugs for prostate-related urinary symptoms work but have various side effects, and treatment should be tailored to the individual.

Stiripentol shows promise as a potential treatment for androgen-related diseases but needs more testing.

Pranlukast and mirabegron may work as new diabetes drugs.

Minoxidil and nebivolol can help prevent aortic aging in diabetic mice.

Certain progesterone derivatives can inhibit enzymes and reduce androgenic activity, potentially affecting prostate growth.

Compound 7b is a promising candidate for treating benign prostatic hyperplasia and prostate cancer.

Minoxidil lowers blood pressure more effectively but has more side effects, so try hydralazine first.

Targeting amphiregulin may improve treatment for fibrotic diseases and cancer.

Non-drug methods effectively managed agitation in a patient with a heart device, leading to improved mental function.

Finasteride reduces certain behaviors caused by D1-like receptor agonists but not by D2-like receptor agonists in mice.